A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Clinical trial NCT07012044 · RECRUITING

Trial details

NCT number: NCT07012044
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Post Cytotoxic Therapy Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Start date: 2026-06-09
Primary completion: 2027-03-31
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.